Biote Corp (BTMD)
6.14
+0.08
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
6.13
-0.01
(-0.16%)
Pre-Market: 20:00
Biote Shareholders Equity (Quarterly): -130.34M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -130.34M |
| June 30, 2024 | -143.34M |
| March 31, 2024 | -35.40M |
| December 31, 2023 | -29.40M |
| September 30, 2023 | -40.53M |
| June 30, 2023 | -46.40M |
| Date | Value |
|---|---|
| March 31, 2023 | -48.54M |
| December 31, 2022 | -44.46M |
| September 30, 2022 | -37.18M |
| June 30, 2022 | -24.95M |
| December 31, 2021 | 4.125M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-143.34M
Minimum
Jun 2024
4.125M
Maximum
Dec 2021
-52.40M
Average
-40.53M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| American Shared Hospital Services | 26.42M |
| Omnicell Inc | 1.231B |
| Astrana Health Inc | 704.62M |
| Cryo-Cell International Inc | -9.559M |
| P3 Health Partners Inc | 120.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 101.25M |
| Total Liabilities (Quarterly) | 228.08M |
| Debt to Equity Ratio | -0.9114 |
| Current Ratio | 1.505 |
| Net Debt Paydown Yield | -0.37% |